Biphasic effect of prostaglandin E2 in a rat model of esophagitis mediated by EPI receptors: Relation to pepsin secretion

Digestion

Volumn 72, Issue 2-3, 2005, Pages 109-118

  Yamato, Masanori ^a   Nagahama, Kenji ^a   Kotani, Tohru ^a   Kato, Shinichi ^a   Takeuchi, Koji ^a  

^a KYOTO PHARMACEUTICAL UNIVERSITY   (Japan)

Author keywords

Acid reflux esophagitis; EP receptor subtype; Nonsteroidal antiinflammatory drugs; Pepsin; Prostaglandin E2; Rat model, acid reflux esophagitis

Indexed keywords

17 PHENYLPROSTAGLANDIN E2; 5 (4 CHLOROPHENYL) 1 (4 METHOXYPHENYL) 3 TRIFLUOROMETHYL 1H PYRAZOLE; CYCLOOXYGENASE 1 INHIBITOR; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITOR; ENDOPROSTANOID RECEPTOR; ENDOPROSTANOID RECEPTOR 1; INDOMETACIN; ONO AE 829; PEPSTATIN; PROSTAGLANDIN E2; PROSTAGLANDIN RECEPTOR BLOCKING AGENT; PROSTAGLANDIN RECEPTOR STIMULATING AGENT; PROSTANOID RECEPTOR; ROFECOXIB; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIET RESTRICTION; DOSE RESPONSE; ESOPHAGITIS; ESOPHAGUS INJURY; ESOPHAGUS MUCOSA; FORESTOMACH; LOW DRUG DOSE; MALE; NONHUMAN; PEPSIN SECRETION; PRIORITY JOURNAL; PYLORUS; RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE INHIBITORS; CYTOPROTECTION; DINOPROSTONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESOPHAGITIS; GASTRIC ACID; GASTRIC MUCOSA; INDOMETHACIN; MALE; PEPSIN A; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, PROSTAGLANDIN E;

EID: 27144539183     PISSN: 00122823     EISSN: None     Source Type: Journal    
DOI: 10.1159/000088365     Document Type: Article

References (44)

1. DeMeester TR, Wernly JA, Bryant GH, Little AG, Skinner DB: Clinical and in vitro analysis of determinants of gastroesophageal competence: a study of the principles of antireflux surgery. Am J Surg 1979;137:39-46.
2. Hunt RH: Importance of pH control in the management of GERD. Arch Intern Med 1999;159:649-657.
3. 2-receptor antagonist. Scand J Gastroenterol 1988;23(suppl 146):201-213.
4. 2-receptor antagonists. Scand J Gastroenterol 1989;24(suppl 166):88-93.
5. 2-receptor antagonist, on reflux esophagitis in rats through capsaicin-sensitive afferent neurons. J Pharmacol Sci 2003;93:55-61.
6. Robert A, Nezamis JE, Lancaster C, Hanchar AJ: Cytoprotection by prostaglandins in rats: prevention of gastric necrosis produced by alcohol, HCl, NaOH, hypertonic NaCl and thermal injury. Gastroenterology 1979;77:433-443.
7. 2 in rat stomachs. Aliment Pharmacol Ther 2000;14(suppl 1):18-25.
8. Takeuchi K, Araki H, Komoike Y, Umeda M, Suzuki K: Adaptive gastric cytoprotection is mediated by prostaglandin EP1 receptors: a study using rats and knockout mice. J Pharmacol Exp Ther 2001;297:1160-1165.
9. Moncada S, Ferreira SH, Vane JR: Prostaglandins as potentiators of increased vascular permeability in inflammation. Nature 1973;246:215-219.
10. Goyal RK: Deleterious effects of prostaglandins on esophageal mucosa. Gastroenterology 1980;78:1085-1087.
11. 2. Gastroenterology 1986;90:32-39.
12. 2 aggravates gastric mucosal injury induced by histamine in rats: possible role of the increased mucosal vascular permeability. Gastroenterology 1987;93:1276-1286.
13. Coleman RA, Smith WL, Narumiya S: International Union of Pharmacology classification of prostanoid receptors: properties, distribution, and structure of the receptors and their subtypes. Pharmacol Rev 1994;46:205-229.
14. Lanza FL: Endoscopie studies of gastric and duodenal injury after the use of ibuprofen, aspirin, and other nonsteroidal anti-inflammatory agents. Am J Med 1984;77:19-24.
15. Levi S, Goodlad RA, Lee CY, Stamp G, Walport MJ, Wright NA, Hodgson HJ: Inhibitory effect of non-steroidal anti-inflammatory drugs on mucosal cell proliferation associated with gastric ulcer healing. Lancet 1990;336:840-843.
16. Konturek PK, Brzozowski T, Konturek SJ, Dembinski A: Role of epidermal growth factor, prostaglandin, and sulfhydryls in stress-induced gastric lesions. Gastroenterology 1990;99:1607-1615.
17. Wang JY, Yamasaki S, Takeuchi K, Okabe S: Delayed healing of acetic acid-induced gastric ulcers in rats by indomethacin. Gastroenterology 1989;96:393-402.
18. Whittle BJ: Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981;80:94-98.
19. Wallace JL, McKnight W, Reuter BK, Vergnolle N: NSAID-induced gastric damage in rats: requirement for inhibition of both cyclooxygenase 1 and 2. Gastroenterology 2000;119:706-714.
20. Gretzer B, Maricic N, Respondek M, Schuligoi R, Peskar BM: Effects of specific inhibition of cyclo-oxygenase-1 and cyclo-oxygenase-2 in the rat stomach with normal mucosa and after acid challenge. Br J Pharmacol 2001;132:1565-1573.
21. Tanaka A, Araki H, Komoike Y, Hase S, Takeuchi K: Inhibition of both COX-1 and COX-2 is required for development of gastric damage in response to nonsteroidal antiinflammatory drugs. J Physiol Paris 2001;95:21-27.
22. Tanaka A, Hase S, Miyazawa T, Takeuchi K: Up-regulation of COX-2 by inhibition of COX-1: a key to NSAID-induced intestinal damage. J Pharmacol Exp Ther 2002;300:754-761.
23. Nagahama K, Yamato M, Takeuchi K: Essential role of pepsin in pathogenesis of acid reflux esophagitis in rats. Dig Dis Sci 2005; in press.
24. Inatomi N, Nagaya H, Takami K, Shino A, Satoh H: Effects of a proton pump inhibitor, AG-1749 (lansoprazole), on reflux esophagitis and experimental ulcers in rats. Jpn J Pharmacol 1991;55:437-451.
25. 2-activated housekeeping Cl channels in the basolateral membrane of rat gastric parietal cells. Jpn J Physiol 1999;49:365-372.
26. 2/EP3 signaling regulates tumor-associated angiogenesis and tumor growth. J Exp Med 2003;197:221-232.
27. Kabashima K, Saji T, Murata T, Nagamachi M, Matsuoka T, Segi E, Tsuboi K, Sugimoto Y, Kobayashi T, Miyachi Y, Ichikawa A, Narumiya S: The prostaglandin receptor EP4 suppresses colitis, mucosal damage and SD4 cell activation in the gut. J Clin Invest 2002;109:883-893.
28. Takeuchi K, Yagi K, Kato S, Ukawa H: Roles of prostaglandin E-receptor subtypes in gastric and duodenal bicarbonate secretion in rats. Gastroenterology 1997;113:1553-1559.
29. 2-stimulated mucus secretion by rabbit gastric epithelial cells. Biochem Pharmacol 1999;58:1997-2002.
30. Aoi M, Aihara E, Nakashima M, Takeuchi K: Participation of prostaglandin receptor EP4 subtype in duodenal bicarbonate secretion in rats. Am J Physiol Gastrointest Liver Physiol 2004;287:G96-G103.
31. 2 on gastric acid secretion through different EP receptor subtypes in the rat. Am J Physiol Gastrointest Liver Physiol 2005;289:G64-G69.
32. Anson ML: The estimation of pepsin, trypsin, papain and cathepsin with hemoglobin. J Gen Physiol 1938;22:79-89.
33. Mantry P, Shah A, Sundaram U: Celecoxib associated esophagitis: review of gastrointestinal side effects from cox-2 inhibitors. J Clin Gastroenterol 2003;37:61-63.
34. Bigard MA, Pelletier AL: Esophageal complications of non steroidal antiinflammatory drugs. Gastroenterol Clin Biol 2004;28 Spec No 3:C58-C61.
35. Northway MG, Libshitz HI, Osborne BM, Feldman MS, Mamel JJ, West JH, Szwarc IA: Radiation esophagitis in the opossum: radioprotection with indomethacin. Gastroenterology 1980;78:883-892.
36. Takeuchi K, Komoike Y, Takeeda M, Ukawa H: Gastric mucosal ulcerogenic responses following barrier disruption in knockout mice lacking prostaglandin EP1 receptors. Aliment Pharmacol Ther 2002;16:74-82.
37. Hirata T, Ukawa H, Yamakuni H, Kato S, Takeuchi K: Cyclooxygenase isozymes in acute mucosal ulcerogenic and functional responses following barrier disruption in rat stomachs. Br J Pharmacol 1997;122:447-454.
38. Holzer P, Livingston EH, Saria A, Guth PH: Sensory neurons mediate protective vasodilatation in rat gastric mucosa. Am J Physiol 1991;260(3 Pt 1):G363-G370.
39. Lanas AI, Blas JM, Ortego J, Soria J, Sainz R: Adaptation of esophageal mucosa to acid- and pepsin-induced damage: role of nitric oxide and epidermal growth factor. Dig Dis Sci 1997;42:1003-1012.
40. Defize J, Hunt RH: Effect of hydrochloric acid and prostaglandins on pepsinogen synthesis and secretion in canine gastric chief cell monolayer cultures. Gut 1989;30:774-781.
41. Goldberg HI, Dodds WJ, Gee S, Montgomery C, Zboralske FF: Role of acid and pepsin in acute experimental esophagitis. Gastroenterology 1969;56:223-230.
42. Hirschowitz BI: Pepsin and esophagitis. Yale J Biol Med 1991;72:133-143.
43. Hirschowitz BI: A critical analysis, with appropriate controls, of gastric acid and pepsin secretion in clinical esophagitis. Gastroenterology 1991;101:1149-1158.
44. Umezawa H, Aoyagi T, Morishima H, Matsuzaki M, Hamada M, Takeuchi T: Pepstatin, a new pepsin inhibitor produced by actinomycetes. J Antibiot (Tokyo) 1970;23:259-262.